about
Impact of radiotherapy in the management of locally advanced extrahepatic cholangiocarcinoma.Efficacy of epidermal growth factor receptor targeting in advanced chordoma: case report and literature review.Concomitant administration of weekly oxaliplatin, fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a Groupe Coordinateur MultidisciplinairSolitary fibrous tumor in the round ligament of the liver: a fortunate intraoperative discovery.Radio(chemo)therapy in Elderly Patients with Esophageal Cancer: A Feasible Treatment with an Outcome Consistent with Younger Patients.Primary leiomyosarcoma of the seminal vesicle: case report and review of the literatureVolumetric-modulated arc therapy for left-sided breast cancer and all regional nodes improves target volumes coverage and reduces treatment time and doses to the heart and left coronary artery, compared with a field-in-field technique.Leukocytosis and neutrophilia predict outcome in locally advanced esophageal cancer treated with definitive chemoradiation.Solitary fibrous tumor of the prostate: case report and review of the literature.Primary synovial sarcoma of the thyroid gland: case report and review of the literature.High-grade soft tissue sarcoma arising in a desmoid tumor: case report and review of the literature.Gastrointestinal Stromal Tumour with Synchronous Bone Metastases: A Case Report and Literature ReviewAnal cancer: French Intergroup Clinical Practice Guidelines for diagnosis, treatment and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, SNFCP).[Granulocyte- colony stimulating factor (G-CSF) use in clinical practice in patients receiving chemotherapy for breast cancer: The Opaline Study].Impact of the Siewert Classification on the Outcome of Patients Treated by Preoperative Chemoradiotherapy for a Nonmetastatic Adenocarcinoma of the Oesophagogastric Junction.
P50
Q31145431-77FA8A25-CA13-4234-BF1A-4B8CAB196124Q33274256-02328560-64F3-44EF-957A-AEE5C1CB343BQ33378806-373A8D05-8F52-4B5E-874C-1CE78CC78DFEQ33401603-03F38CD4-1C08-42AC-83BC-B7549C153BC0Q33633972-2F9C9D43-F92C-4654-B055-AEF4C7819DF3Q33975569-99C3B662-479E-4705-B062-6B9C37909638Q36234752-80AFCBE2-5E23-4EB4-AD6F-29DC92B1456FQ37706953-C68A0F23-E95E-4CB1-8B9E-003CA871A9D9Q37989459-EF160726-DACF-4E64-A9DE-D99E486CE1FEQ38191597-012593F2-00DC-43ED-828A-5A7606FFD454Q38656475-6A67F89E-801D-4A9F-8108-08E7CC60378FQ39137592-A327159C-40B9-451F-B7AC-20AA337F0AB6Q39370469-B5AF1881-1124-46F5-8E91-7D59FA056139Q41104065-E23582B3-E012-4F7E-A201-54E811077DB2Q41904650-BC792287-322F-4E51-93A9-527017B5195A
P50
description
onderzoeker
@nl
name
Laurence Moureau-Zabotto
@ast
Laurence Moureau-Zabotto
@en
Laurence Moureau-Zabotto
@es
Laurence Moureau-Zabotto
@nl
Laurence Moureau-Zabotto
@sl
type
label
Laurence Moureau-Zabotto
@ast
Laurence Moureau-Zabotto
@en
Laurence Moureau-Zabotto
@es
Laurence Moureau-Zabotto
@nl
Laurence Moureau-Zabotto
@sl
prefLabel
Laurence Moureau-Zabotto
@ast
Laurence Moureau-Zabotto
@en
Laurence Moureau-Zabotto
@es
Laurence Moureau-Zabotto
@nl
Laurence Moureau-Zabotto
@sl